Page last updated: 2024-08-20

e-z cinnamic acid and Dyslipidemia

e-z cinnamic acid has been researched along with Dyslipidemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Barre, DE; Mizier-Barre, KA1

Reviews

1 review(s) available for e-z cinnamic acid and Dyslipidemia

ArticleYear
The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus.
    Endocrine regulations, 2020, Apr-01, Volume: 54, Issue:2

    Topics: Acrolein; Animals; Caffeic Acids; Chlorogenic Acid; Cinnamates; Coumaric Acids; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Hyperglycemia; Hypertension; Inflammation; Obesity, Abdominal; Polypharmacy

2020